Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Probes for Cardiovascular, Endocrine and Other - Preclinical
Preparation and Preclinical Evaluation of [11C]3Br-pHPG to Determine its Feasibility as a Bromine-76/77 Theranostic Agent to Target Norepinephrine Transporter in Neuroendocrine Tumors
Helen SaTsu, Allen Brooks, Xia Shao, Jason Witek, Paul Ellison and Peter Scott
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241560;
Helen SaTsu
1University of Michigan
Allen Brooks
1University of Michigan
Xia Shao
1University of Michigan
Jason Witek
2Jason Witek
Paul Ellison
3University of Wisconsin-Madison
Peter Scott
1University of Michigan

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
Preparation and Preclinical Evaluation of [11C]3Br-pHPG to Determine its Feasibility as a Bromine-76/77 Theranostic Agent to Target Norepinephrine Transporter in Neuroendocrine Tumors
Helen SaTsu, Allen Brooks, Xia Shao, Jason Witek, Paul Ellison, Peter Scott
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241560;
Preparation and Preclinical Evaluation of [11C]3Br-pHPG to Determine its Feasibility as a Bromine-76/77 Theranostic Agent to Target Norepinephrine Transporter in Neuroendocrine Tumors
Helen SaTsu, Allen Brooks, Xia Shao, Jason Witek, Paul Ellison, Peter Scott
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241560;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.